Literature DB >> 20857105

Metachronous cancer in the stomach remnant.

Christos S Katsios.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 20857105     DOI: 10.1007/s00268-010-0806-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  15 in total

1.  Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

2.  Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 3.  Systems medicine: a real approach for future personalized oncology?

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-03       Impact factor: 2.533

4.  Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

5.  Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Authors:  Dimitrios H Roukos; Andreas Tzakos; George Zografos
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

6.  From tumor size and HER2 status to systems oncology for very early breast cancer treatment.

Authors:  Dimitrios H Roukos; Dimosthenis Ziogas
Journal:  Expert Rev Anticancer Ther       Date:  2010-02       Impact factor: 4.512

7.  Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery.

Authors:  Isao Nozaki; Junichirou Nasu; Yoshiro Kubo; Minoru Tanada; Rieko Nishimura; Akira Kurita
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

Review 8.  Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-01       Impact factor: 5.225

Review 9.  Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.

Authors:  Dimosthenis Ziogas; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-03-26       Impact factor: 5.344

10.  Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-10-20       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.